Global Vascular Access Devices Market Size Study & Forecast, by Product (Short PIVCs, Huber Needles, Midline Catheters, PICCs, CVCs, Dialysis Catheters, Implantable Ports) and End Use and Regional Forecasts 2025-2035

The Global Vascular Access Devices Market, valued at nearly USD 8.64 billion in 2024, is projected to expand at a steady CAGR of 4.70% between 2025 and 2035. Vascular access devices, which serve as essential lifelines in clinical practice, enable direct access to a patient’s bloodstream for administering medications, nutrition, dialysis, and chemotherapy, as well as for diagnostic testing. The market has been witnessing consistent momentum, fueled by rising incidences of chronic illnesses such as cancer, kidney disease, and cardiovascular disorders, all of which necessitate long-term vascular access. Simultaneously, advancements in device design that improve patient comfort, reduce infection risk, and extend catheter lifespan are shaping the industry’s forward trajectory. Increasing demand for minimally invasive procedures and the growing preference for home-based therapies have also been central to propelling adoption across diverse healthcare settings.

The rise in the prevalence of chronic diseases worldwide has created a compelling need for advanced vascular access solutions. According to the World Health Organization, chronic illnesses account for nearly 74% of global deaths, underlining the essential role of vascular access devices in treatment delivery. Additionally, the dialysis patient population continues to expand rapidly, particularly in developing nations, driving significant usage of catheters and implantable ports. The oncology sector remains another dominant contributor to market growth, with chemotherapy regimens requiring reliable vascular access for prolonged treatment cycles. Meanwhile, healthcare providers are increasingly investing in cutting-edge vascular devices with antimicrobial coatings and improved insertion techniques to mitigate complications such as thrombosis or bloodstream infections—ensuring better patient outcomes and stronger adoption rates.

From a regional perspective, North America continues to hold the lion’s share of the market, thanks to its well-established healthcare infrastructure, advanced reimbursement systems, and rising prevalence of cancer and kidney failure. The United States, in particular, is experiencing growing demand for central venous catheters and PICCs in both hospital and home care environments. Europe follows closely, benefiting from robust research activity and wide-scale adoption of innovative vascular access technologies. Meanwhile, the Asia-Pacific region is expected to chart the fastest growth during the forecast horizon, owing to an expanding patient pool, surging healthcare expenditure, and government-driven investments in improving dialysis and oncology care. Countries such as India and China, with rapidly urbanizing populations and a rising chronic disease burden, are emerging as high-potential markets for device manufacturers seeking to scale operations.

Major market players included in this report are:
• Becton, Dickinson and Company
• B. Braun Melsungen AG
• Teleflex Incorporated
• Smiths Medical
• AngioDynamics, Inc.
• Nipro Medical Corporation
• ICU Medical, Inc.
• Cook Medical
• Medtronic plc
• Terumo Corporation
• Fresenius Medical Care AG & Co. KGaA
• C.R. Bard (a Becton, Dickinson Company)
• Vygon SA
• Poly Medicure Ltd.
• Baxter International Inc.

Global Vascular Access Devices Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period – 2025-2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Product:
• Short PIVCs
• Huber Needles
• Midline Catheters
• PICCs
• CVCs
• Dialysis Catheters
• Implantable Ports

By End Use:
• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Home Healthcare

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more